Case File
efta-02570334DOJ Data Set 11OtherEFTA02570334
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02570334
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Jeffrey Epstein <[email protected]>
Sent:
Friday, May 31, 2013 11:06 PM
To:
Thomas Turrin
Subject:
Re:
have you used 3115 before , i don't think that r=quires an amendmed return ,
On Fri, May 31, 2013 at 6:24 PM, Thomas Turrin=<
wrote:
Jeffrey,
Once I have the purchase docs, entity structure and yr 2011 financial =ata (including usage data), I'll evaluate
filing an amended return. =Business use percentage will be a key factor re: deductibility of bonus de=reciation.
Best,
Tom
Sent from my Verizon Wireless 4G LTE =ROID
Jeffrey Epstein <[email protected] <mailto:[email protected]> wrote:
torn the plane was purchased in 8 / 2011. . tha= year bonus depreciation was allowed. can we use the form
3115 to cl=im it now.? in 2011 there was also bonus depreciation of 100pe= cent for certain aircraft. not sure if this
applies to leons. we will get the full purchase docs next week
* *****
***********
*******
* *********
*** ********
** *******
*****
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
=A0
EFTA_R1_01738237
EFTA02570334
CONFIDENTIALITY STATEMENT: The information contained in this elect=onic communication, including any and
all attachments and enclosures, may be privileged and is strictly confidential, intended s=lely for the use of the person(s)
identified above to receive this communi=ation. If you are not the person(s) identified above to receive this
commu=ication, you are hereby notified that you may not disclose print, copy, disseminate, or otherwise use the
i=formation contained herein. If you are an employee or agent of the person(=) identified above to receive this
communication and, as such, you have be=n authorized to deliver this communication to such person(s), you may
disclose, print, copy, disseminate, or otherwis= use the information contained in this communication solely for the
purpos= of such delivery. Unauthorized interception and/or use of this communicat=on are/is strictly prohibited and
may be punishable by law. If you have received this communication in error= please reply and notify the sender (only) of
that fact and delete the com=unication, including any and all attachments and enclosures, from your com=uter or other
electronic device on which you may have received this communication.
CIRCULAR 230 DISCLOSURE:
=/font> To insure compliance with requirements imposed by the Internal R=venue Service, we inform you that
any tax advice contained in this communication (including any and all attachments), unles= expressly stated otherwise,
was not intended or written to be used and ca=not be used for the purpose of (i) avoiding tax-related penalties imposed
=y the Internal Revenue Code or (ii) promoting, marketing, or recommending to another party any transactio=(s) or tax-
related matter(s) addressed herein. This communication may not =e forwarded (other than to the addressee(s)
identified above) without our =xpress written consent.
*************** ••••••••_
The information contained in this c=mmunication is confidential, may be attorney-client privileged, may constitute
inside information, and is intended only for the use of the a=dressee. It is the property of Jeffrey Epstein Unauthorized
use, di=closure or copying of this communication or any part thereof is strictl= prohibited and may be unlawful. If you
have received this communication in error, p=ease notify us immediately by return e-mail or by e-mail to
[email protected], =nd destroy this communication and all copies thereof, including all attachm=nts. copyright -all
rights reserved
2
EFTA_R1_01738238
EFTA02570335
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.